Motus GI Holdings, Inc. (MOTS): Price and Financial Metrics


Motus GI Holdings, Inc. (MOTS): $0.90

-0.07 (-7.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MOTS Stock Summary

  • With a market capitalization of $45,065,181, Motus GI Holdings Inc has a greater market value than just 8.76% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for MOTS is 0.01 -- better than merely 9.11% of US stocks.
  • MOTS's price/sales ratio is 459.85; that's higher than the P/S ratio of 98.53% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Motus GI Holdings Inc are OCX, FUV, SMAR, EPAY, and DOMO.
  • MOTS's SEC filings can be seen here. And to visit Motus GI Holdings Inc's official web site, go to www.motusgi.com.

MOTS Stock Price Chart Interactive Chart >

Price chart for MOTS

MOTS Price/Volume Stats

Current price $0.90 52-week high $2.74
Prev. close $0.96 52-week low $0.62
Day low $0.89 Volume 1,096,606
Day high $0.98 Avg. volume 3,420,464
50-day MA $1.42 Dividend yield N/A
200-day MA $1.15 Market Cap 41.87M

Motus GI Holdings, Inc. (MOTS) Company Bio


Motus GI Holdings, Inc., a development stage company, engages in developing single-use medical device systems in the United States. It is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The company is based in Tirat Carmel, Israel.


MOTS Latest News Stream


Event/Time News Detail
Loading, please wait...

MOTS Latest Social Stream


Loading social stream, please wait...

View Full MOTS Social Stream

Latest MOTS News From Around the Web

Below are the latest news stories about Motus GI Holdings Inc that investors may wish to consider to help them evaluate MOTS as an investment opportunity.

Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy

Motus GI Holdings Inc (NASDAQ: MOTS ) has submitted a 510(k) application to the FDA for … Full story available on Benzinga.com

Benzinga | April 6, 2021

Motus GI Submits 510(k) Application to FDA for the Pure-Vu System for Upper GI Endoscopy

FORT LAUDERDALE, Fla., April 06, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (“FDA”) for a version of the Pure-Vu® System that is compatible with gastroscopes used during upper gastrointestinal (GI) endoscopy procedures to remove blood, blood clots and debris in order to provide a clear field-of-view for the endoscopist. The device is designed to integrate with therapeutic gastroscopes to enable safe and rapid cleansing during the procedure, while prese...

Yahoo | April 6, 2021

Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q4 2020 Results - Earnings Call Transcript

Motus GI Holdings, Inc. (MTS) Q4 2020 Earnings Conference Call March 16, 2021 04:30 p.m. ET Company Representatives Tim Moran - Chief Executive Officer Andy Taylor - Chief Financial Officer Mark Pomeranz - President, Chief Operating Officer Garth Russell - LifeSci Advisors Conference Call Participants Drew Stafford - Piper Sandler...

SA Transcripts on Seeking Alpha | March 17, 2021

FXNEWS24 |Motus GI Holdings, Inc. (MOTS) Studies This autumn Loss, Lags Income Estimates | UK Forex Reviews

Motus GI Holdings, Inc. (MOTS) Studies This autumn Loss, Lags Income Estimates | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News

FXNews24 | March 16, 2021

Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0.00% and -61.29%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | March 16, 2021

Read More 'MOTS' Stories Here

MOTS Price Returns

1-mo -39.60%
3-mo -47.06%
6-mo 1.12%
1-year 34.61%
3-year -79.31%
5-year N/A
YTD -5.06%
2020 -58.60%
2019 -26.37%
2018 N/A
2017 N/A
2016 N/A

Continue Researching MOTS

Want to see what other sources are saying about Motus GI Holdings Inc's financials and stock price? Try the links below:

Motus GI Holdings Inc (MOTS) Stock Price | Nasdaq
Motus GI Holdings Inc (MOTS) Stock Quote, History and News - Yahoo Finance
Motus GI Holdings Inc (MOTS) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.999 seconds.